Home › All Companies › VCEL › Current Report

Vericel Corp (VCEL) — Current Report

AI-Powered SEC Filing Analysis

← All VCEL filings
Latest Current Report Filed: 2026-01-13

Key Insights

  • Vericel Corporation provided preliminary financial results for fiscal year 2025, including estimated revenue, net income, gross margin, and adjusted EBITDA margin.
  • The company's financial statements for 2025 have not been finalized or audited, so the preliminary estimates are subject to change and the actual results may differ materially.
  • Vericel will participate in the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026, where they will provide additional financial and business updates.
Sentiment: Positive Significance: 6/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-01-13. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Other reports for Vericel Corp

Insider Trading

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.